These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35113411)

  • 1. BECN1 protein expression is associated with poor survival in triple negative locally advanced breast cancer.
    Cervantes-Díaz MT; Muñoz-Granados AJ; Olguín-Cruces VA; Ramírez-Torres N; Gutiérrez-Osorio V; Mantilla-Morales A; López-Muñoz E
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):354-366. PubMed ID: 35113411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIK and GRP78 protein expression as possible markers of response to preoperative chemotherapy and survival in breast cancer.
    María Teresa de Jesús CD; Agni Jaim MG; Cindy Karina VV; Víctor Alberto OC; Nicolás RT; Verónica GO; Fabio Abdel SG; Patricia PS; Sergio FH; Eunice LM
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):245-252. PubMed ID: 33678323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.
    Aglan SA; Awad AM; Elwany YN; Shawky S; Salam RMA; Omar RS; Ghazala RAM; Soliman NA; Khedr MI; Kandil LS; Sultan M; Hamed Y; Kandil NS
    Mol Genet Genomics; 2024 May; 299(1):56. PubMed ID: 38787424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
    J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.
    Xu Q; Xu Y; Pan B; Wu L; Ren X; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Zhang X; Wang C; Zhong Y; Zhou L; Liang Z; Zhao H; Sun Q
    Oncotarget; 2016 Dec; 7(49):81815-81829. PubMed ID: 27833085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the protein expression of GRP78 and BIK/NBK with prognostic markers in patients with breast cancer and neoadjuvant chemotherapy.
    López-Muñoz E; Corres-Molina M; García-Hernández N
    J Obstet Gynaecol; 2020 Apr; 40(3):419-426. PubMed ID: 31635499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
    Chen S; Jiang YZ; Huang L; Zhou RJ; Yu KD; Liu Y; Shao ZM
    Clin Cancer Res; 2013 Dec; 19(24):6853-62. PubMed ID: 24141623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.
    Bai YG; Gao GX; Zhang H; Zhang S; Liu YH; Duan XN; Xu L
    Chin Med J (Engl); 2020 Mar; 133(5):552-560. PubMed ID: 32044815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers.
    Yue Y; Astvatsaturyan K; Cui X; Zhang X; Fraass B; Bose S
    PLoS One; 2016; 11(3):e0149661. PubMed ID: 26930401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally Advanced Breast Cancer: Treatment Patterns and Predictors of Survival in a Saudi Tertiary Center.
    Trabulsi NH; Shabkah AA; Ujaimi R; Iskanderani O; Kadi MS; Aljabri N; Sharbatly L; AlOtaibi MN; Farsi AH; Nassif MO; Saleem AM; Akeel NY; Malibary NH; Samkari AA
    Cureus; 2021 Jun; 13(6):e15526. PubMed ID: 34277162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.
    Chaher N; Arias-Pulido H; Terki N; Qualls C; Bouzid K; Verschraegen C; Wallace AM; Royce M
    Breast Cancer Res Treat; 2012 Jan; 131(2):437-44. PubMed ID: 21360074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
    Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
    Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple Negative Breast Cancer: Expression of Folate Receptor Alpha in Indian population.
    Gajaria P; Kadu V; Patil A; Desai S; Shet T
    Ann Diagn Pathol; 2020 Dec; 49():151598. PubMed ID: 32919338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].
    Benbrahim Z; Berrada A; Amaadour L; Zahra El M'rabet F; Elfatemi H; Elfakir S; Mellas N; Arifi S
    Gynecol Obstet Fertil Senol; 2017 Nov; 45(11):604-608. PubMed ID: 29100820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
    Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
    Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transforming growth factor-β1 in triple negative breast cancer patients.
    Zhang M; Wu J; Mao K; Deng H; Yang Y; Zhou E; Liu J
    Int J Surg; 2017 Sep; 45():72-76. PubMed ID: 28754615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.